To compare the diagnostic performance of radiomic features extracted from T2-weighted and arterial-phase T1-weighted MRI sequences using univariate, machine and deep learning analysis and to assess their effectiveness in predicting axillary lymph node (ALN) metastasis in breast cancer patients. We retrospectively analyzed MRI data from 100 breast cancer patients, comprising 52 metastatic and 103 non-metastatic lymph nodes. Radiomic features were extracted from T2-weighted and subtracted arterial-phase T1-weighted images. Feature normalization and selection were performed. Various machine learning classifiers, including logistic regression, gradient boosting, random forest, and neural networks, were trained and evaluated. Diagnostic performance was assessed using metrics such as area under the curve (AUC), sensitivity, specificity, and accuracy. T2-weighted imaging provided strong performance in multivariate modeling, with the neural network achieving the highest AUC (0.978) and accuracy (91.1%), showing statistically significant differences over models. The stepwise logistic regression model also showed competitive results (AUC = 0.796; accuracy = 73.3%). In contrast, arterial-phase T1-weighted imaging features performed better when analyzed individually, with the best univariate AUC reaching 0.787. When multivariate modeling was applied to arterial-phase features, the best-performing logistic regression model achieved an AUC of 0.853 and accuracy of 77.8%. Radiomic analysis of T2-weighted MRI, particularly through deep learning models like neural networks, demonstrated the highest overall diagnostic performance for predicting metastatic ALNs. In contrast, arterial-phase T1-weighted features showed better results in univariate analysis. These findings support the integration of radiomic features, especially from T2-weighted sequences, into multivariate models to enhance noninvasive preoperative assessment.

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe, life-threatening complication of pulmonary embolism with pulmonary hypertension (PH). The combination of insufficient resolution of thrombi following pulmonary emboli and accompanying microvascular disease results in PH. Advances in imaging can offer better insight into CTEPH diagnosis and management, but lack of disease awareness among radiologists has been shown to be a cause of CTEPH misdiagnosis or delayed diagnosis. This review highlights features pertinent to CTEPH diagnosis. The primary focus is on different modalities with their distinctive signs and newly developed technologies employing artificial intelligence systems.

Surgical navigation is a rapidly evolving multidisciplinary system that plays a crucial role in precision medicine. Surgical-navigation systems have substantially enhanced modern surgery by improving the precision of resection, reducing invasiveness, and enhancing patient outcomes. However, clinicians, engineers, and professionals in other fields often view this field from their own perspectives, which usually results in a one-sided viewpoint. This article aims to provide a thorough overview of the recent advancements in surgical-navigation systems and categorizes them on the basis of their unique characteristics and applications. Established techniques (e.g., radiography, intraoperative computed tomography [CT], magnetic resonance imaging [MRI], and ultrasound) and emerging technologies (e.g., photoacoustic imaging and near-infrared [NIR]-II imaging) are systematically analyzed, highlighting their underlying mechanisms, methods of use, and respective advantages and disadvantages. Despite substantial progress, the existing navigation systems face challenges, including limited accuracy, high costs, and extensive training requirements for surgeons. Addressing these limitations is crucial for widespread adoption of these technologies. The review emphasizes the need for developing more intelligent, minimally invasive, precise, personalized, and radiation-free navigation solutions. By integrating advanced imaging modalities, machine learning algorithms, and real-time feedback mechanisms, next-generation surgical-navigation systems can further enhance surgical precision and patient safety. By bridging the knowledge gap between clinical practice and engineering innovation, this review not only provides valuable insights for surgeons seeking optimal navigation strategies, but also offers engineers a deeper understanding of clinical application scenarios.

Achieving high image quality for temporal frames in dynamic positron emission tomography (PET) is challenging due to the limited statistic especially for the short frames. Recent studies have shown that deep learning (DL) is useful in a wide range of medical image denoising tasks. In this paper, we propose a model-based neural network for dynamic PET image denoising. The inter-frame spatial correlation and intra-frame structural consistency in dynamic PET are used to establish the kernel space-based multidimensional sparse (KMDS) model. We then substitute the inherent forms of the parameter estimation with neural networks to enable adaptive parameters optimization, forming the end-to-end neural KMDS-Net. Extensive experimental results from simulated and real data demonstrate that the neural KMDS-Net exhibits strong denoising performance for dynamic PET, outperforming previous baseline methods. The proposed method may be used to effectively achieve high temporal and spatial resolution for dynamic PET. Our source code is available at https://github.com/Kuangxd/Neural-KMDS-Net/tree/main.

Glioblastoma (GBM) carries poor prognosis; epidermal-growth-factor-receptor (EGFR) mutations further shorten survival. We propose a fully automated MRI-based decision-support system (DSS) that segments GBM and classifies EGFR status, reducing reliance on invasive biopsy. The segmentation module (UNet SI) fuses multiresolution, entropy-ranked shearlet features with CNN features, preserving fine detail through identity long-skip connections, to yield a Lightweight 1.9 M-parameter network. Tumour masks are fed to an Inception ResNet-v2 classifier via a 512-D bottleneck. The pipeline was five-fold cross-validated on 98 contrast-enhanced T1-weighted scans (Memorial Hospital; Ethics 24.12.2021/008) and externally validated on BraTS 2019. On the Memorial cohort UNet SI achieved Dice 0.873, Jaccard 0.853, SSIM 0.992, HD95 24.19 mm. EGFR classification reached Accuracy 0.960, Precision 1.000, Recall 0.871, AUC 0.94, surpassing published state-of-the-art results. Inference time is ≤ 0.18 s per slice on a 4 GB GPU. By combining shearlet-enhanced segmentation with streamlined classification, the DSS delivers superior EGFR prediction and is suitable for integration into routine clinical workflows.

Background and Objectives: Neurofibromatosis type 1 is a genetic disorder characterized by the development of numerous neurofibromas (NFs) throughout the body. Whole-body MRI (WB-MRI) is the clinical standard for detection and longitudinal surveillance of NF tumor growth. Existing interactive segmentation methods fail to combine high lesion-wise precision with scalability to hundreds of lesions. This study proposes a novel interactive segmentation model tailored to this challenge. Methods: We introduce MOIS-SAM2, a multi-object interactive segmentation model that extends the state-of-the-art, transformer-based, promptable Segment Anything Model 2 (SAM2) with exemplar-based semantic propagation. MOIS-SAM2 was trained and evaluated on 119 WB-MRI scans from 84 NF1 patients acquired using T2-weighted fat-suppressed sequences. The dataset was split at the patient level into a training set and four test sets (one in-domain and three reflecting different domain shift scenarios, e.g., MRI field strength variation, low tumor burden, differences in clinical site and scanner vendor). Results: On the in-domain test set, MOIS-SAM2 achieved a scan-wise DSC of 0.60 against expert manual annotations, outperforming baseline 3D nnU-Net (DSC: 0.54) and SAM2 (DSC: 0.35). Performance of the proposed model was maintained under MRI field strength shift (DSC: 0.53) and scanner vendor variation (DSC: 0.50), and improved in low tumor burden cases (DSC: 0.61). Lesion detection F1 scores ranged from 0.62 to 0.78 across test sets. Preliminary inter-reader variability analysis showed model-to-expert agreement (DSC: 0.62-0.68), comparable to inter-expert agreement (DSC: 0.57-0.69). Conclusions: The proposed MOIS-SAM2 enables efficient and scalable interactive segmentation of NFs in WB-MRI with minimal user input and strong generalization, supporting integration into clinical workflows.

A significant challenge in solid tumors is reliably distinguishing confounding pathologies from malignant neoplasms on routine imaging. While radiomics methods seek surrogate markers of lesion heterogeneity on CT/MRI, many aggregate features across the region of interest (ROI) and miss complex spatial relationships among varying intensity compositions. We present a new Graph-Radiomic Learning (GrRAiL) descriptor for characterizing intralesional heterogeneity (ILH) on clinical MRI scans. GrRAiL (1) identifies clusters of sub-regions using per-voxel radiomic measurements, then (2) computes graph-theoretic metrics to quantify spatial associations among clusters. The resulting weighted graphs encode higher-order spatial relationships within the ROI, aiming to reliably capture ILH and disambiguate confounding pathologies from malignancy. To assess efficacy and clinical feasibility, GrRAiL was evaluated in n=947 subjects spanning three use cases: differentiating tumor recurrence from radiation effects in glioblastoma (GBM; n=106) and brain metastasis (n=233), and stratifying pancreatic intraductal papillary mucinous neoplasms (IPMNs) into no+low vs high risk (n=608). In a multi-institutional setting, GrRAiL consistently outperformed state-of-the-art baselines - Graph Neural Networks (GNNs), textural radiomics, and intensity-graph analysis. In GBM, cross-validation (CV) and test accuracies for recurrence vs pseudo-progression were 89% and 78% with >10% test-accuracy gains over comparators. In brain metastasis, CV and test accuracies for recurrence vs radiation necrosis were 84% and 74% (>13% improvement). For IPMN risk stratification, CV and test accuracies were 84% and 75%, showing >10% improvement.

Medical imaging provides critical evidence for clinical diagnosis, treatment planning, and surgical decisions, yet most existing imaging models are narrowly focused and require multiple specialized networks, limiting their generalization. Although large-scale language and multimodal models exhibit strong reasoning and multi-task capabilities, real-world clinical applications demand precise visual grounding, multimodal integration, and chain-of-thought reasoning. We introduce Citrus-V, a multimodal medical foundation model that combines image analysis with textual reasoning. The model integrates detection, segmentation, and multimodal chain-of-thought reasoning, enabling pixel-level lesion localization, structured report generation, and physician-like diagnostic inference in a single framework. We propose a novel multimodal training approach and release a curated open-source data suite covering reasoning, detection, segmentation, and document understanding tasks. Evaluations demonstrate that Citrus-V outperforms existing open-source medical models and expert-level imaging systems across multiple benchmarks, delivering a unified pipeline from visual grounding to clinical reasoning and supporting precise lesion quantification, automated reporting, and reliable second opinions.

Neuroimaging is a ubiquitous tool for evaluating patients with neurological diseases. The global demand for magnetic resonance imaging (MRI) studies has risen steadily, placing significant strain on health systems, prolonging turnaround times, and intensifying physician burnout \cite{Chen2017-bt, Rula2024-qp-1}. These challenges disproportionately impact patients in low-resource and rural settings. Here, we utilized a large academic health system as a data engine to develop Prima, the first vision language model (VLM) serving as an AI foundation for neuroimaging that supports real-world, clinical MRI studies as input. Trained on over 220,000 MRI studies, Prima uses a hierarchical vision architecture that provides general and transferable MRI features. Prima was tested in a 1-year health system-wide study that included 30K MRI studies. Across 52 radiologic diagnoses from the major neurologic disorders, including neoplastic, inflammatory, infectious, and developmental lesions, Prima achieved a mean diagnostic area under the ROC curve of 92.0, outperforming other state-of-the-art general and medical AI models. Prima offers explainable differential diagnoses, worklist priority for radiologists, and clinical referral recommendations across diverse patient demographics and MRI systems. Prima demonstrates algorithmic fairness across sensitive groups and can help mitigate health system biases, such as prolonged turnaround times for low-resource populations. These findings highlight the transformative potential of health system-scale VLMs and Prima's role in advancing AI-driven healthcare.

Medical imaging provides critical evidence for clinical diagnosis, treatment planning, and surgical decisions, yet most existing imaging models are narrowly focused and require multiple specialized networks, limiting their generalization. Although large-scale language and multimodal models exhibit strong reasoning and multi-task capabilities, real-world clinical applications demand precise visual grounding, multimodal integration, and chain-of-thought reasoning. We introduce Citrus-V, a multimodal medical foundation model that combines image analysis with textual reasoning. The model integrates detection, segmentation, and multimodal chain-of-thought reasoning, enabling pixel-level lesion localization, structured report generation, and physician-like diagnostic inference in a single framework. We propose a novel multimodal training approach and release a curated open-source data suite covering reasoning, detection, segmentation, and document understanding tasks. Evaluations demonstrate that Citrus-V outperforms existing open-source medical models and expert-level imaging systems across multiple benchmarks, delivering a unified pipeline from visual grounding to clinical reasoning and supporting precise lesion quantification, automated reporting, and reliable second opinions.